Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinomaXuejun Xu(Baylor College of Medicine), Donglai Chen(Sun Yat-sen University)Cancer MedicineMarch 6, 202310.1002/cam4.5731Cited by 14SaveCiteExport RISWatch citationsRelated PapersChemical Probes that Competitively and Selectively Inhibit Stat3 Activation|PLoS ONE|2009|129